Sleep Study Market Size
Sleep Study Market size was valued at USD 6.5 billion in 2023 and is anticipated to showcase growth at 12.3% CAGR from 2024 and 2032. Growing prevalence of sleep disorders, availability of reimbursement for sleep disorder diagnosis and treatment, and growing adoption of home sleep testing and telemedicine services is driving the revenue growth in market. Additionally, advances in wearable sleep disorder monitoring and diagnostic devices are also adding to the revenue growth in the market.
Sleep study involves the diagnostic processes and procedures used for evaluating, diagnosing, and monitoring sleep disorders and sleep-related conditions. Sleep study helps to identify disruptions in normal sleep patterns, and in understanding the underlying causes, to guide appropriate treatment.
Sleep Study Market Report Attributes
Report Attribute |
Details |
Base Year: | 2023 |
---|
Sleep Study Market Size in 2023: | USD 6.5 Billion |
---|
Forecast Period: | 2024 - 2032 |
---|
Forecast Period 2024 - 2032 CAGR: | 12.3% |
---|
2032 Value Projection: | USD 18.3 Billion |
---|
Historical Data for: | 2021 – 2023 |
---|
No. of Pages: | 123 |
---|
Tables, Charts & Figures: | 224 |
Segments covered: | Testing services, Indications, End-user, and Region |
---|
Growth Drivers: | - Growing prevalence of sleep disorders
- Availability of reimbursement for sleep disorder diagnosis and treatment
- Growing adoption of home sleep testing and telemedicine services
- Advances in wearable sleep disorder monitoring and diagnostic devices
|
---|
Pitfalls & Challenges: | - High cost associated to sleep monitoring devices
- Lack of coordinated care due to fragmentation of services
|
---|
Sleep Study Market Trends
- The growing use of telehealth services in sleep studies is enabling remote monitoring and virtual consultations, making sleep studies more accessible and convenient. This is particularly beneficial for the geriatric population, which is significantly affected by sleep disorders. Telemedicine plays a crucial role in the management of sleep disorders, particularly sleep apnea and insomnia through facilitating remote monitoring of CPAP therapy, allowing for the tracking of key parameters such as pressure, air leaks, apnea-hypopnea index, and patient compliance.
- Moreover, vendors offering sleep study services are leveraging artificial intelligence and machine learning tools for efficiently analyzing sleep data, providing accurate diagnosis, and preparing personalized treatment plans. According to a December 2023 study published by National Center for Biotechnology Information, artificial intelligence is being significantly used for sleep staging, respiratory events scoring, insomnia characterization, prediction of circadian rhythm from gene expression, and phenotyping of OSA.
- Adoption of portable and wearable devices in sleep monitoring has increased in sleep studies owing to their convenience, affordability, and ability to measure sleep variables in a natural environment. According to a study published by National Center for Biotechnology Information in April 2024, patients are more frequently sharing sleep data obtained from their wearable devices with healthcare providers, and the growing accessibility of commercial devices and advanced research/clinical tools has spurred the widespread integration of wearables in research.
Sleep Study Market Analysis
Based on testing services, the market is segmented into home sleep testing and in-lab testing. The in-lab testing segment is further segmented into polysomnography testing, CPAP/ BiPAP titration, split night polysomnography, multiple sleep latency test, maintenance of wakefulness test, and epilepsy monitoring. The in-lab testing segment held the majority of market share in 2023 of about 82.9%.
- In-lab testing offers comprehensive monitoring of various physiological parameters such as EEG, EOG, ECG, and SpO2, in comparison to home sleep testing, the application of which is limited to certain types of test. For example, polysomnography, the gold standard for diagnosing sleep disorders, is typically performed across sophisticated laboratories.
- Additionally, availability of reimbursement coverage for in-lab testing is helping to overcome higher cost related concerns for in-lab testing services. For instance, Medicare in U.S. covers 20% of the cost after the Part B deductible is met. As a result, the adoption of in-lab testing is high for sleep study.
Based on indication, the sleep study market is classified into obstructive sleep apnea, insomnia, restless leg syndrome, circadian rhythm sleeping disorders, narcolepsy, rapid eye movement sleep disorders, periodic limb movement disorders, and bruxism. The obstructive sleep apnea segment dominated the market with a revenue of about USD 2.6 billion in 2023.
- Leading share of obstructive sleep apnea segment can be attributed to an increasing prevalence of sleep apnea and growing awareness for its timely diagnosis. According to a January 2023 study published by National Center for Biotechnology Information, obstructive sleep apnea affected about 936 million adults aged 30-69 globally. Owing to high prevalence of sleep apnea, the demand for testing services to timely diagnose and monitor sleep apnea has surged globally, contributing to the leading share of the segment.
- Moreover, rapid adoption of home sleep testing services such as home sleep apnea test, type 3 home-sleep test, and type 2 home sleep test offering testing for obstructive sleep apnea through using portable monitoring and wearable devices is also fueling the revenue growth in the segment.
Based on end-user, the sleep study market is classified into hospitals, sleep testing centers, and home care settings. The hospitals segment dominated the market with a revenue of about USD 3.4 billion in 2023.
- Availability of advanced and sophisticated sleep diagnostic devices such as polysomnography equipment and easy access to advanced imaging and in-lab test is enabling the patients to prefer hospitals for sleep study, that can facilitate in-depth monitoring of various physiological parameters during sleep. This contributes to a leading share of hospitals in market.
- Furthermore, hospitals offer comprehensive patient care and are well suited to handling complex and severe cases of sleep disorders such as severe obstructive sleep apnea, central sleep apnea, and narcolepsy. As a result, patients with severe sleep disorder conditions prefer hospitals for sleep disorder diagnosis, monitoring, and treatment.
North America sleep study market accounted for 42.1% of market share in global market in 2023 and is predicted to reach USD 7.4 billion by 2032.
- Leading share of North America can be attributed to increasing demand of sleep study among patients suffering from sleep disorders. According to the 2023 report from American Sleep Apnea Association, about 50 to 70 million people in U.S. had sleep disorders. With substantial awareness among people for available treatments, the demand for sleep study has spurred in the region.
- Additionally, availability of substantial reimbursement and coverage from Center for Medicare & Medicaid Services for the diagnosis and treatment of sleep disorders is also promoting the patients with limited budget to opt for in-lab testing services for sleep study. This enhanced access to sleep study services is contributing to the market growth in the region.
The U.S. sleep study market was valued at USD 2.4 billion in 2023 and is anticipated to grow at a CAGR of 12% over the forecast period.
- According to the Sleep Foundation, sleep disorders are becoming common in the U.S., with about 30 million individuals suffering from obstructive sleep apnea. As a result, the demand for the timely treatment and diagnosis of obstructive sleep apnea conditions is driving the adoption of sleep studies in the country.
- Furthermore, increasing availability of U.S. FDA cleared home sleep apnea testing devices in the country is also driving the adoption of home sleep testing services. For instance, in 2022, U.S. FDA cleared nine home sleep apnea testing devices. A sudden rise in U.S. FDA clearances can be attributed to improved quality of these devices and emergence of COVID-19 pandemic, that raised the demand for home-testing services for sleep study.
Germany sleep study market is expected to show significant growth opportunities during the forecast period.
- Significant rise in awareness for timely monitoring and diagnosis of sleep disorders owing to campaigns such as “Come, sweet sleep!” and availability of digital sleep improvement program in Germany is driving the revenue growth of market.
- Additionally, growing use of advanced telemedicine services for enabling home sleep testing is also contributing to an increased revenue growth of Germany in market. In 2021 Germany witnessed significant changes in telemedicine adoption due to government policies on obligatory electronic patient record, and due to an increasing number of prescribable digital health applications in the country. This has led to an easy availability of teleconsultation and monitoring services for home-based sleep studies in the country.
India sleep study market is anticipated to grow remarkably over the coming years.
- Increasing awareness towards sleep disorder treatments and diagnosis and increasing growth in sleep labs is driving the revenue growth of market in India. According to the Koninklijke Philips N.V., due to rising demand for sleep study in India, the company trained about 500 sleep technicians and guided the launch of over 850 sleep labs in India by March 2021.
- Additionally, government of India is promoting teleconsultation services for sleep disorder treatment, which is increasingly gaining popularity. For instance, Tele MANAS, the government-run national tele-mental health helpline announced to record the highest number of calls that were seeking help for sleep disorders. The increasing adoption of teleconsultation services is further driving the adoption of home sleep testing services in the country, aiding to the revenue growth in market.
Sleep Study Market Share
The market for sleep study is characterized by fragmentation due to the presence of numerous established and small-scale vendors worldwide offering variety of sleep testing services. Established market players focus towards using advance sleep testing equipment to offer efficient services to the patients. Furthermore, established vendors have substantial availability of trained and experienced workforce that offer them cutting edge over their competitors. Smaller companies rely on low pricing strategies for their services to compete with established vendors globally.
Sleep Study Market Companies
Prominent players operating in the sleep study industry include:
- Circle Health Group
- Cleveland Clinic
- Imperial College Healthcare NHS Trust
- Interdisciplinary Center of Sleep Medicine
- International Institute of Sleep
- Koninklijke Philips N.V.
- Korea University Medicine
- London Sleep Centre
- Medical Service Company
- MedStar Health
- Midwest Sleep Services Inc.
- Millennium Sleep Lab
- SleepMedSite
- SOVA Sleep Services Inc.
- USA Sleep Diagnostic.
Sleep Study Industry News:
- In May 2021, Medical Service Company announced the acquisition of Metz Medical, a company offers sleep and respiratory focused durable medical equipment’s. The acquisition has enabled the Medical Service Company to gain access to new payers in Wisconsin (U.S.).
- In December 2021, Millenium Sleep Lab announced its partnership with SomnoMed a manufacturer of oral appliances for sleep apnea. The partnership will enable Millenium Sleep Lab to provide patients with a simple process for testing and treating sleep apnea.
The sleep study market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Testing Services
- In-lab testing
- Polysomnography testing
- CPAP/ BiPAP titration
- Split night polysomnography
- Multiple sleep latency test
- Epilepsy monitoring
- Maintenance of wakefulness test
- Home sleep testing
Market, By Indication
- Obstructive sleep apnea
- Insomnia
- Restless leg syndrome
- Circadian rhythm sleeping disorders
- Narcolepsy
- Rapid eye movement sleep disorders
- Periodic limb movement disorders
- Bruxism
Market, By End-user
- Hospitals
- Sleep testing centers
- Home care settings
The above information is provided for the following regions and countries:
- North America
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa